Surgical Oncology

  • Raphael E Pollock

Part of the Cancer Treatment and Research book series (CTAR, volume 90)

Table of contents

  1. Front Matter
    Pages i-xi
  2. John M. Skibber
    Pages 29-49
  3. Cynthia A. Corpron, Richard J. Andrassy
    Pages 51-69
  4. Mark A. Schusterman, Geoffrey L. Robb, Helen E. Tadjalli
    Pages 71-89
  5. Peter W. T. Pisters, Barry W. Feig, Denis H. Y. Leung, Murray F. Brennan
    Pages 91-107
  6. Douglas B. Evans, Jeffrey E. Lee, Peter W. T. Pisters, Chusilp Charnsangavej, Lee M. Ellis, Paul J. Chiao et al.
    Pages 109-125
  7. Alan W. Yasko, Mark E. Johnson
    Pages 127-147
  8. Ann M. Gillenwater, Randal S. Weber
    Pages 149-169
  9. Kelly K. Hunt, Merrick I. Ross
    Pages 171-201
  10. Paul F. Mansfield, Kelly K. Hunt
    Pages 203-211
  11. Julie A. Miller, Jeffrey A. Norton
    Pages 213-225
  12. S. Eva Singletary, Kapil Dhingra, Di-Hua Yu
    Pages 253-271
  13. Steven A. Curley
    Pages 273-307
  14. Jeffrey W. Milsom, Pierenrico Marchesa, Andrea Vignali
    Pages 309-329
  15. Barry J. Roseman, Mark S. Roh
    Pages 331-345
  16. David M. Ota
    Pages 347-356
  17. Back Matter
    Pages 357-371

About this book


Among the standard oncology modalities, surgical oncology is singular in that it lacks a separate board certification or even an added qualification mecha­ nism. 'Card-carrying' surgical oncologists are certified by the American Board of Surgery, as are all other general surgeons. What distinguishes the surgical oncologist is a set of cognitive skills rather than a specific armamentarium of surgical techniques. This different conceptual framework is derived from ex­ tensive additional training that leads to an in-depth understanding of the natural history and biologic behavior of the various solid tumor systems. Equipped with this perspective, the surgical oncologist is particularly well positioned to integrate the various available therapeutic modalities into a coherent care program for the solid tumor patient. As a central theme, the chapters of this book demonstrate that increasingly sophisticated diagnostic and staging approaches are helping to move chemo­ therapy and radiotherapy into the preoperative neoadjuvant setting. This fundamental alteration is based on the awareness that even early-stage solid tumor disease is frequently systemic at the time of presentation, at least on a subclinical level. And although the primary tumor may be controllable by surgery with radiotherapy, the uncontrolled (and initially clinically unappar­ ent) distant disease ultimately determines patient survival. The other perspec­ tive driving the neoadjuvant approach is an emerging awareness that for most solid tumor systems, neoadjuvant treatment responses can facilitate less muti­ lating surgery with comparable levels of local disease control.


Staging carcinoma classification neuroendocrine tumor surgery

Editors and affiliations

  • Raphael E Pollock
    • 1
  1. 1.M.D. Anderson Cancer CenterThe University of TexasHoustonUSA

Bibliographic information

  • DOI
  • Copyright Information Kluwer Academic Publishers 1997
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4613-7826-6
  • Online ISBN 978-1-4615-6165-1
  • Series Print ISSN 0927-3042
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology